APPLICATION
ANDA210152
TYPE
ANDA
ORIGINAL APPROVAL
2020-04-08
LATEST ACTION
2022-05-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
APIXABANDiscontinued
APIXABAN 2.5MG · TABLET · ORAL
APIXABANDiscontinued
APIXABAN 5MG · TABLET · ORAL
Approval history
2022-05-20Labeling · Supplement 2 · standardAP
2022-05-20Labeling · Supplement 1 · standardAP
2020-04-08UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.